November 13, 2020 Comments Off on New patent for Merck Sharp drug STEGLUJAN Posted in: Patent Added Annual Drug Patent Expirations for STEGLUJAN Steglujan is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There are five…
The post New patent for Merck Sharp drug STEGLUJAN appeared first on DrugPaten…
November 12, 2020 Comments Off on New patent for Ucb Inc drug BRIVIACT Posted in: Patent Added Annual Drug Patent Expirations for BRIVIACT Briviact is a drug marketed by Ucb Inc and is included in three NDAs. It is available from one supplier. There are four patents…
The post New patent for Ucb Inc drug BRIVIACT appeared first on DrugPatentWatch…